The National Company Law Tribunal (NCLT) asked lenders of Sterling Biotech how they had accepted the one-time settlement (OTS) offer from the promoters of the bankrupt firm. The NCLT also plans to write to central...
BioNTech hires banks for IPO worth up to $800 million: sources
BioNTech, Europe’s largest unlisted biotech firm by staff numbers, has hired banks to prepare for an initial public offering (IPO) worth as much as $800 million as early as this year, people familiar with the plan told...
Biotech startup Gossamer defies U.S. shutdown with risky IPO move
Gossamer Bio Inc said on Wednesday it has tweaked its initial public offering (IPO) so it can proceed despite a U.S. government shutdown that has frozen stock market debuts, an extraordinary move that the biotechnology...
HC dismisses Monsanto plea against CCI probe of directors
In a setback to US biotechnology major MonsantoNSE 0.29 %, the Delhi High Court on Tuesday dismissed its plea to stop the Competition Commission from probing its top officials’ role in a case related to alleged...
Moderna to raise $604 million in upsized IPO, braving market jitters
Moderna Inc (MRNA.O) will sell around $604.3 million in shares in its initial public offering (IPO), the biotech company said on Thursday, braving stock market jitters to sell more stock than originally planned. In the...
AstraZeneca-Backed ADC Therapeutics Weighs IPO, Sale
ADC Therapeutics SA, a Swiss biotechnology company whose backers include U.K. drugmaker AstraZeneca Plc, is in the early stages of exploring options, including an initial public offering, amid growing interest in...
Chinese biotech firm Ascletis raises $400 million in HK IPO: sources
Chinese biotech Ascletis Pharma Inc (1672.HK) raised $400 million after pricing its IPO in the middle of an indicative range, three people said, in the first such Hong Kong listing under rules designed to attract early...
Bankruptcy court admits lenders insolvency plea against Sterling Biotech
The bankruptcy court has admitted the insolvency plea against Sterling BiotechNSE -3.33 % filed by Andhra Bank – a move by banks to recover their dues amidst probe by investigative agencies on allegation of misuse of...
Fujifilm to buy two biotech units from JXTG for $800 million
Fujifilm Holdings said it would buy two biotechnology units of Japan’s JXTG Holdings Inc for about $800 million, as it looks to boost its healthcare business. Fujifilm is seeking growth through buying businesses...
Biotech M&A explodes with $27.5 billion of January deals
Biotech deal-making is the hottest in more than a decade with $27.5 billion of transactions agreed this month and bankers reporting an above-average number of discussions that could lead to fresh activity through 2018...
Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom
French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. The transaction is...
Biotech M&A takes off as Sanofi and Celgene spend $20 billion
Biotech deal activity exploded on Monday with French drugmaker Sanofi and U.S.-based Celgene spending a combined total of more than $20 billion to add new products for haemophilia and cancer to their medicine cabinets...
